| scholarly article | Q13442814 |
| P356 | DOI | 10.1212/01.WNL.0000225184.14578.D3 |
| P698 | PubMed publication ID | 16790606 |
| P2093 | author name string | Duyckaerts C | |
| Frébourg T | |||
| Campion D | |||
| Bou J | |||
| Guyant-Maréchal L | |||
| Hannequin D | |||
| Laquerrière A | |||
| Dumanchin C | |||
| Le Ber I | |||
| Dugny F | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 644-651 | |
| P577 | publication date | 2006-06-21 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Valosin-containing protein gene mutations: clinical and neuropathologic features | |
| P478 | volume | 67 |
| Q33849069 | A Brazilian family with hereditary inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia |
| Q47414379 | A Brazilian family with inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia linked to the VCP pGly97Glu mutation. |
| Q41487960 | A case report comparing clinical, imaging and neuropsychological assessment findings in twins discordant for the VCP p.R155C mutation |
| Q57165581 | A cross-sectional analysis of clinical evaluation in 35 individuals with mutations of the valosin-containing protein gene |
| Q35194634 | A network of RNA and protein interactions in Fronto Temporal Dementia |
| Q53050086 | A novel VCP mutation underlies scapuloperoneal muscular dystrophy and dropped head syndrome featuring lobulated fibers. |
| Q36565507 | A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse |
| Q26744554 | Autoimmune Myopathies: Where Do We Stand? |
| Q38114942 | Caspase-6 as a novel early target in the treatment of Alzheimer's disease |
| Q38156177 | Cdc48: a swiss army knife of cell biology |
| Q43488914 | Characterization of the Asian myopathy patients with VCP mutations |
| Q39778164 | Clinical exome sequencing for cerebellar ataxia and spastic paraplegia uncovers novel gene-disease associations and unanticipated rare disorders |
| Q38635213 | Clinical spectrum of valosin containing protein (VCP)-opathy |
| Q53292162 | Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. |
| Q35532028 | Decreases in valosin-containing protein result in increased levels of tau phosphorylated at Ser262/356. |
| Q58623082 | Drosophilaand Mouse Models of Hereditary Myopathy Caused by Mutations in VCP/p97 |
| Q35018480 | Exercise training reverses skeletal muscle atrophy in an experimental model of VCP disease |
| Q37241079 | FTD and ALS: a tale of two diseases |
| Q33922335 | FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration |
| Q48650516 | Fronto-temporal lobar degeneration: neuropathology in 60 cases |
| Q36817228 | Frontotemporal lobar degeneration: current concepts in the light of recent advances |
| Q37799472 | Genetic Causes of Frontotemporal Degeneration |
| Q36745555 | Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia |
| Q60521494 | Genotype–phenotype links in frontotemporal lobar degeneration |
| Q48370935 | Hereditary spastic paraplegia caused by a mutation in the VCP gene |
| Q34979278 | Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant |
| Q46130063 | Indications for a genetic association of a VCP polymorphism with the pathogenesis of sporadic Paget's disease of bone, but not for TNFSF11 (RANKL) and IL-6 polymorphisms |
| Q41810203 | Molecular mechanisms of OLIG2 transcription factor in brain cancer. |
| Q24611300 | Motor neuron involvement in multisystem proteinopathy: implications for ALS |
| Q28080241 | Mutations in the Human AAA+ Chaperone p97 and Related Diseases |
| Q49077271 | Neuropathologic classification of dementias: introduction |
| Q33685317 | Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration |
| Q64236121 | Next Generation Sequencing Analysis in Early Onset Dementia Patients |
| Q36605617 | Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis |
| Q26782984 | Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia |
| Q21245242 | Progranulin in frontotemporal lobar degeneration and neuroinflammation |
| Q36922853 | Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3β. |
| Q28254281 | Progranulin: normal function and role in neurodegeneration |
| Q41776157 | Psychiatric Presentation of Frontotemporal Dementia Associated with Inclusion Body Myopathy due to the VCP Mutation (R155H) in a French Family. |
| Q39035327 | Psychological Impact of Predictive Genetic Testing in VCP Inclusion Body Myopathy, Paget Disease of Bone and Frontotemporal Dementia |
| Q35462835 | Rapamycin and chloroquine: the in vitro and in vivo effects of autophagy-modifying drugs show promising results in valosin containing protein multisystem proteinopathy |
| Q89578449 | Sorting Rare ALS Genetic Variants by Targeted Re-Sequencing Panel in Italian Patients: OPTN, VCP, and SQSTM1 Variants Account for 3% of Rare Genetic Forms |
| Q35110776 | Targeted excision of VCP R155H mutation by Cre-LoxP technology as a promising therapeutic strategy for valosin-containing protein disease |
| Q34178673 | The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis. |
| Q36926070 | The genetics of frontotemporal lobar degeneration |
| Q27316347 | The homozygote VCP(R¹⁵⁵H/R¹⁵⁵H) mouse model exhibits accelerated human VCP-associated disease pathology |
| Q37926529 | The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis. |
| Q50471241 | Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice. |
| Q30487226 | VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death |
| Q35635102 | Valosin containing protein associated fronto-temporal lobar degeneration: clinical presentation, pathologic features and pathogenesis |
| Q33589965 | Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease |
| Q37452177 | Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia |
| Q34890838 | Valosin-containing protein gene mutations: cellular phenotypes relevant to neurodegeneration |
| Q53162756 | [Multilocular Paget's disease in IBMPFD syndrome. A case report with 14-year follow-up]. |
Search more.